Tesla shares (TSLA)

Key Updates

Tesla shares declined 2.13% to $364.19, breaking below the critical $370 support level and marking the lowest price point in the current downtrend. YTD losses have now deepened to -19.02%, with the stock experiencing sustained selling pressure across all timeframes. The latest news reveals another postponement of the next-generation Roadster to late April 2025, reinforcing concerns about execution delays as the company pivots resources toward robotaxis and humanoid robots while discontinuing Model S and Model X production later this year.

Current Trend

The downtrend has accelerated with consistent declines across all measured periods: -2.13% (1d), -1.02% (5d), -12.75% (1m), -17.30% (6m), and -19.02% YTD. The stock has broken through multiple support levels, falling from $380 to $372 and now to $364, indicating deteriorating technical momentum. The failure to hold the $370 level suggests further downside risk, with no clear support visible until previous consolidation zones. The sustained selling pressure reflects mounting investor concerns about capital allocation, cash flow deterioration, and the shift away from the core automotive business.

Investment Thesis

The investment thesis centers on Tesla's transformation from an electric vehicle manufacturer to an AI and autonomous vehicle technology leader. Bank of America's $460-$488 price target assigns 54% of Tesla's valuation to robotaxi operations ($422 billion) and autonomous driving software ($313 billion), compared to just 21% for traditional automotive operations ($345 billion). The thesis depends on successful execution of robotaxi expansion from two cities to nine by 2026, scaling FSD adoption from 1.1 million to 8.7 million customers by 2030, and achieving $1.58 cost per mile economics versus $3.41 for traditional ride-sharing. Additional value drivers include the Optimus humanoid robot ($30+ billion valuation) and energy business ($90 billion). However, this thesis requires regulatory approvals in China and Europe, successful chip manufacturing through the Terafab Project, and maintaining technological leadership despite projected negative free cash flow of $4.1 billion in 2026.

Thesis Status

The investment thesis faces mounting execution challenges. The Roadster postponement represents the latest in a series of delays dating back to 2017, raising credibility concerns about management's ability to deliver on ambitious timelines. The decision to discontinue Model S and Model X while redirecting capacity to robotaxis represents a high-stakes strategic pivot that increases business model risk. The projected negative free cash flow of $4.1 billion in 2026—the first since 2018—combined with over $20 billion in capex (excluding the potentially $300 billion Terafab investment) creates significant financial strain. While analyst valuations remain optimistic at $460-$488, the 26-28% gap to current prices suggests the market is pricing in substantial execution risk and skepticism around the AI investment thesis. The thesis remains intact but increasingly dependent on flawless execution across multiple fronts simultaneously.

Key Drivers

The primary near-term catalyst is the Terafab Project launch in 7 days, which will determine whether Tesla can credibly execute vertical integration into chip manufacturing. The robotaxi volume production beginning next month represents the critical inflection point for the autonomous vehicle thesis, with expansion to seven additional markets planned for H1 2026. The third-generation Optimus unveiling expected by end of March 2025 could provide a positive catalyst if the technology demonstrates commercial viability. However, the discontinuation of Model S and Model X later this year removes established revenue streams during a critical transition period. Free cash flow deterioration remains the overarching concern, with Wall Street projecting negative $4.1 billion FCF in 2026 as capital intensity peaks.

Technical Analysis

Tesla has broken decisively below the $370 support level, trading at $364.19 and establishing a clear downtrend pattern. The stock has failed to hold any meaningful support levels over the past month, declining from $417 to current levels—a 12.75% drop. The 6-month decline of 17.30% and YTD loss of 19.02% indicate persistent distribution and lack of institutional support. The previous resistance at $390-$393 now appears distant, requiring a 7-8% rally just to retest those levels. Volume patterns suggest continued selling pressure without signs of capitulation or accumulation. The technical setup remains bearish with no clear support visible until the stock establishes a new base, potentially requiring a catalyst to reverse momentum.

Bull Case

• Robotaxi market dominance potential: Bank of America assigns $422 billion valuation to robotaxi business with projections of capturing up to 50% of the global market, and Morgan Stanley forecasting 5 million robotaxis by 2035, representing transformational revenue opportunity. Source
• Superior autonomous driving economics: Tesla's camera-only approach enables $1.58 cost per mile at scale versus $3.41 for traditional ride-sharing, providing 54% cost advantage that could drive rapid market share gains and profitability. Source
• FSD software scaling opportunity: With only 1.1 million of 8.9 million vehicles having purchased FSD subscriptions, Tesla has substantial runway to monetize existing fleet, with BofA projecting 8.7 million customers by 2030 representing 8x growth. Source
• Diversified value drivers beyond automotive: Optimus humanoid robot valued at over $30 billion and energy business at $90 billion provide multiple paths to value creation independent of core EV operations. Source
• Vertical integration through chip manufacturing: Terafab Project launching in 7 days could enable Tesla to control critical AI chip supply chain, with AI5 chip targeted for volume production in 2027 addressing capacity constraints from TSMC, Samsung, and Micron. Source

Bear Case

• Free cash flow turning negative for first time since 2018: Wall Street projects negative $4.1 billion FCF in 2026 as capital expenditures exceed $20 billion (excluding Terafab), with UBS estimating Terafab could require $30 billion initially and $300 billion at full capacity, creating unprecedented financial strain. Source
• Chronic execution delays eroding credibility: Next-generation Roadster postponed again to late April 2025, marking continuous delays since 2017 announcement with original 2020 production target, demonstrating pattern of overpromising and underdelivering on product timelines. Source
• High-risk strategic pivot away from proven revenue streams: Discontinuing Model S and Model X later this year while redirecting capacity to unproven robotaxi business concentrates risk in untested market requiring regulatory approvals across multiple jurisdictions. Source
• Limited FSD adoption despite large installed base: Only 1.1 million of 8.9 million vehicles (12%) have purchased FSD subscriptions, indicating customer skepticism about value proposition and suggesting challenging path to BofA's 8.7 million customer target by 2030. Source
• Regulatory uncertainty in key markets: Robotaxi expansion requires regulatory approval in China and Europe where autonomous vehicle frameworks remain undeveloped, with only two cities currently operational and seven more planned for 2026 representing minimal near-term scale. Source